PHARMING GROUP NV (PHARM.AS) Stock Analyst Ratings
AMS:PHARM - Euronext Amsterdam - NL0010391025 - Common Stock - Currency: EUR
ChartMill assigns a Buy % Consensus number of 89% to PHARM.AS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.14. This target is 696.17% above the current price.
PHARM.AS was analyzed by 14 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about PHARM.AS.
In the previous month the buy percentage consensus was at a similar level.
PHARM.AS was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.